Syndax Pharmaceuticals Inc (SNDX)
Investing Cash Flow
$175.48M
TTM · Period ending: · USD
SNDX Investing Cash Flow
Latest reported$175.48Mperiod ending
Latest reported$175.48Mperiod ending
SNDX TTM Cash from Investing (-$4.03M → $175.48M)
TTM investing cash flow
High-resolution chart · PNG
SNDX investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 175,483,000 | |
| 234,284,000 | |
| 290,036,000 | |
| -60,515,000 | |
| -46,097,000 | |
| -26,234,000 | |
| -219,775,000 | |
| 32,908,000 | |
| -13,862,000 | |
| -1,705,000 | |
| 117,609,000 | |
| -3,730,000 | |
| -50,600,000 | |
| -174,455,000 | |
| -186,188,000 | |
| -108,515,000 | |
| -75,091,000 | |
| -3,463,000 | |
| -40,873,000 | |
| -45,057,000 | |
| -52,413,000 | |
| -152,705,000 | |
| -142,530,000 | |
| -71,794,000 | |
| -78,705,000 | |
| -19,024,000 | |
| 12,781,000 | |
| 22,147,000 | |
| 13,291,000 | |
| 51,506,000 | |
| 51,398,000 | |
| 36,980,000 | |
| 40,393,000 | |
| -15,446,000 | |
| -17,027,000 | |
| 2,760,000 | |
| 3,889,000 | |
| 39,820,000 | |
| -18,380,000 | |
| -57,269,000 | |
| -72,732,000 | |
| -89,322,000 | |
| -61,669,000 | |
| -46,211,000 | |
| -38,798,000 | |
| -19,048,000 | |
| 1,888,000 | |
| -64,000 | |
| -72,000 | |
| -2,575,000 | |
| -4,027,000 | |
| 25,000 |